These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17499311)

  • 1. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo.
    Fang L; Moore XL; Gao XM; Dart AM; Lim YL; Du XJ
    Life Sci; 2007 May; 80(23):2154-2160. PubMed ID: 17499311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
    Xu X; Su YL; Shi JY; Lu Q; Chen C
    Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candesartan cilexetil attenuated cardiac remodeling by improving expression and function of mitofusin 2 in SHR.
    Wang Z; Niu Q; Peng X; Li M; Liu K; Liu Y; Liu J; Jin F; Li X; Wei Y
    Int J Cardiol; 2016 Jul; 214():348-57. PubMed ID: 27085127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
    Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
    J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.
    Yu H; Guo Y; Mi L; Wang X; Li L; Gao W
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):205-11. PubMed ID: 21106870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene
    Sun D; Li C; Liu J; Wang Z; Liu Y; Luo C; Chen Y; Wen S
    DNA Cell Biol; 2019 Aug; 38(8):796-807. PubMed ID: 31295012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of cardiac hypertrophy by mitofusin 2 in neonatal rat cardiomyocytes].
    Chen CL; Shen T; Zheng M; Guo YH; Zhu XJ; Chen GH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):528-32. PubMed ID: 18931719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.
    Li XX; Zhang P; Yang Y; Wang JJ; Zheng YJ; Tan JL; Liu SY; Yan YM; Zhang YY; Cheng YX; Yang HT
    Acta Pharmacol Sin; 2022 Mar; 43(3):588-601. PubMed ID: 33967278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy.
    Zhao Y; Ponnusamy M; Liu C; Tian J; Dong Y; Gao J; Wang C; Zhang Y; Zhang L; Wang K; Li P
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2871-2881. PubMed ID: 28782654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The regulatory mechanism of Raf/MEK/ERK pathway on the rat cardiac hypertrophy induced by transverse aortic constriction].
    Fu DT; Tu J; Cai YQ; Cai ZW; Zhang LZ; Liu JY; Xu SC; Wang DJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):33-38. PubMed ID: 32476371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression.
    Nie X; Fan J; Wang Y; Xie R; Chen C; Li H; Wang DW
    Front Med; 2024 Jun; 18(3):484-498. PubMed ID: 38743133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression.
    Chen H; Du Y; Li Y; Zeng J; Miao J; Jiang X
    J Tradit Chin Med; 2019 Jun; 39(3):346-355. PubMed ID: 32186007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro.
    Pawlikowska P; Gajkowska B; Orzechowski A
    Cell Tissue Res; 2007 Mar; 327(3):571-81. PubMed ID: 17093923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.
    Kinnunen P; Taskinen T; Järvinen M; Ruskoaho H
    Br J Pharmacol; 1991 Feb; 102(2):453-61. PubMed ID: 1826618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin affects vascular smooth muscle cell proliferation and apoptosis through modulation of the mitofusin-2-mediated Ras-Raf-Erk1/2 signaling pathway.
    Zhang W; Shu C; Li Q; Li M; Li X
    Mol Med Rep; 2015 Sep; 12(3):4703-4707. PubMed ID: 26059448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase inhibition reverses impaired Ca
    Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.